Previous 10 | Next 10 |
Natera Reports Fourth Quarter and Year 2020 Financial Results PR Newswire SAN CARLOS, Calif., Feb. 25, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the fo...
Natera to Participate in the Cowen 41st Annual Health Care Conference PR Newswire SAN CARLOS, Calif. , Feb. 23, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a ...
Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call PR Newswire SAN CARLOS, Calif. , Feb. 18, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, and Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced that the two companies have entered into a partnership in the field of personalized oncology. The partnership will pair P...
Natera to Participate in Upcoming Investor Conferences PR Newswire SAN CARLOS, Calif. , Feb. 11, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin , MD, Natera's Sen...
Healthcare lagged the broader market last year, but that can change this year. A cyclical upturn as the pandemic abates and pent-up demand can boost healthcare. Best positioned are industry groups within healthcare that can achieve secular growth beyond the cyclical rise. Biot...
Panorama® SMART Study Confirms Market-Leading Performance in Largest Prospective NIPT Trial to Date Natera introduces Panorama AI, maintaining industry-leading sensitivity for identifying aneuploidies while dramatically lowering the no call rate PR Newswire SA...
SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected Natera introduces Panorama AI, improving upon its industry-leading detection for 22q11.2 microdeletions PR Newswire SAN CARLOS, Calif. , Feb. 1, 2021 /PRNewswire/ -- Natera, Inc. ...
Exact Sciences (EXAS), Natera (NTRA), Personalis (PSNL), and Veracyte (VCYT) are all trading sharply higher today, as Truist Securities initiates coverage with buy recommendations on the stocks.With a price target of $65 and ~21.4% of upside to the previous close, the only laggard in the list...
Natera Files Patent Infringement Suit Against Inivata PR Newswire SAN CARLOS, Calif. , Jan. 20, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed a lawsuit today against Inivata, Ltd. and its wholly-...
News, Short Squeeze, Breakout and More Instantly...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-13 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...